Infinity Pharmaceuticals, Inc.
INFI
INFI은(는) 2023년 9월 13일에 상장 폐지됐어요.
소개: Infinity Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology related treatments. The company operates in only one segment which is drug development.
직원 수: 30
뉴스
INFI에 대한 최신 뉴스 기사를 아직 받지 못했어요.